Rabaja, Ruben E.

HRN: 29-23-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/01/2026
07/08/2026
IVTT
1.5g
Q8H
Nonhealing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: